Novo Nordisk Goodwill and Intangible Assets 2010-2025 | NVO

Novo Nordisk goodwill and intangible assets for the quarter ending March 31, 2025 were $15.433B, a 77.73% increase year-over-year.

  • Novo Nordisk goodwill and intangible assets for 2024 were $16.108B, a 83.65% increase from 2023.
  • Novo Nordisk goodwill and intangible assets for 2023 were $8.771B, a 20.47% increase from 2022.
  • Novo Nordisk goodwill and intangible assets for 2022 were $7.281B, a 6% increase from 2021.

Novo Nordisk Goodwill and Intangible Assets 2010-2025 | NVO

  • Novo Nordisk goodwill and intangible assets for 2024 were $16.108B, a 83.65% increase from 2023.
  • Novo Nordisk goodwill and intangible assets for 2023 were $8.771B, a 20.47% increase from 2022.
  • Novo Nordisk goodwill and intangible assets for 2022 were $7.281B, a 6% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B